 | Up a level |
Valgimigli, Marco; Aboyans, Victor; Angiolillo, Dominick; Atar, Dan; Capodanno, Davide; Halvorsen, Sigrun; James, Stefan; Jüni, Peter; Kunadian, Vijay; Landi, Antonio; Leonardi, Sergio; Mehran, Roxana; Montalescot, Gilles; Navarese, Eliano Pio; Niebauer, Josef; Oliva, Angelo; Piccolo, Raffaele; Price, Susanna; Storey, Robert F; Völler, Heinz; ... (2023). Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC). European heart journal. Cardiovascular pharmacotherapy, 9(5), pp. 462-496. Oxford University Press 10.1093/ehjcvp/pvad032
Navarese, Eliano Pio; Landi, Antonio; Oliva, Angelo; Piccolo, Raffaele; Aboyans, Victor; Angiolillo, Dominick; Atar, Dan; Capodanno, Davide; Fox, Keith A A; Halvorsen, Sigrun; James, Stefan; Jüni, Peter; Kunadian, Vijay; Leonardi, Sergio; Mehran, Roxana; Montalescot, Gilles; Niebauer, Josef; Price, Susanna; Storey, Robert F; Völler, Heinz; ... (2023). Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease. Two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC) and European Association of Preventive Cardiology (EAPC). European heart journal. Cardiovascular pharmacotherapy, 9(3), pp. 271-290. Oxford University Press 10.1093/ehjcvp/pvad016
